Insmed Inc (INSM)vsVoyager Therapeutics Inc (VYGR)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
VYGR
Voyager Therapeutics Inc
$4.03
+2.81%
HEALTHCARE · Cap: $233.63M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 1402% more annual revenue ($606.42M vs $40.37M). INSM leads profitability with a -2.1% profit margin vs -3.0%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
VYGR
Hold35
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Revenue surging 144.3% year-over-year
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -48.3% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : VYGR
The strongest argument for VYGR centers on Price/Book, Revenue Growth. Revenue growth of 144.3% demonstrates continued momentum.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : VYGR
The primary concerns for VYGR are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while VYGR is a hypergrowth play — different risk/reward profiles.
VYGR carries more volatility with a beta of 1.39 — expect wider price swings.
VYGR is growing revenue faster at 144.3% — sustainability is the question.
VYGR generates stronger free cash flow (-31M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 35/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Voyager Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?